EUVIMEDEUVIMED entdecken
Crossref

Glucokinase Inactivation Reduces Lysophosphatidylcholine Accumulation to Alleviate High‐Fat Diet–Induced Hepatic Steatosis

Shanshan Chen, Fang Fang, Ke Xu, Ziyue Zhang, Shuhui Ji, Yadi Huang, Na Li, Jingting Qiao, Junhe Wang, Anting Yu, Ming Liu, Yuxin Fan und 1 weitere

The FASEB Journal · 31.03.2026 · 40 (6)

DOI: 10.1096/fj.202503377r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 10.03.2026. Verfasst von Shanshan Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Diet, High-Fat, Lysophosphatidylcholines, Glucokinase, Fatty Liver. Die Arbeit nennt 34 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Key R&D Program, Tianjin Medical University General Hospital Clinical Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Partial inactivation of glucokinase (GCK) is typically characterized by mild hyperglycemia and a favorable lipid profile compared to type 2 diabetes. Previous studies have shown that GCK activity influences serum lipid profiles in a diet‐dependent manner; however, its role in hepatic lipid metabolism in the context of metabolic dysfunction‐associated steatotic liver disease (MASLD) remains unclear. To address this, we utilized a newly established heterozygous GCK mutation knock‐in mouse model (GCK Mut ) fed either a normal diet (ND) or a high‐fat diet (HFD). Under ND conditions, GCK Mut mice developed mild hyperglycemia without overt hepatic injury but displayed reduced hepatic glycogen storage, likely due to decreased energy flux. Metabolomic analyses further revealed substantial reprogramming of hepatic amino acid and lipid metabolism in GCK Mut mice. Notably, levels of lysophosphatidylcholines (LPCs)—bioactive metabolites implicated in lipotoxicity and the pathogenesis of MASLD—were significantly reduced, as confirmed by ELISA. Under HFD conditions, GCK inactivation markedly attenuated hepatic lipid accumulation, as demonstrated by biochemical quantification and histological analysis. This protective effect was associated with downregulation of genes involved in de novo lipogenesis and fatty acid uptake, as revealed by transcriptomic analyses of primary hepatocytes. Moreover, both the expression of phospholipase A2 (PLA2) and its product LPC were significantly reduced in GCK Mut mice, whereas pharmacologic activation of GCK increased hepatic LPC accumulation. These findings suggest that partial GCK inactivation reprograms hepatic metabolism and mitigates lipid‐induced hepatic stress, highlighting reduced hepatic GCK activity as a potential therapeutic strategy for early intervention in MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatLysophosphatidylcholinesGlucokinaseFatty LiverAnimalsMiceMaleLipid MetabolismLiverMice, Inbred C57BL

Stichwörter der Autor:innen

GCKGKALPCMASLDPLA2T2DMlipid metabolismlipotoxicity

Substanzen

LysophosphatidylcholinesGlucokinase

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
  • Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, the First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.

ORCID-Profile: Yu Fan

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Key R&D Program
  • Tianjin Medical University General Hospital Clinical Research Program
  • Tianjin Key Medical Discipline (Specialty) Construction Project
  • Tianjin Natural Science Foundation
  • Tianjin Medical University Clinical Special Disease Research Center - Neuroendocrine Tumor Clinical Special Disease Research Center.
  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Chen, S., Fang, F., Xu, K., Zhang, Z., Ji, S., Huang, Y., Li, N., Qiao, J., Wang, J., Yu, A., Liu, M., Fan, Y., & Fan, Y. (2026). Glucokinase Inactivation Reduces Lysophosphatidylcholine Accumulation to Alleviate High‐Fat Diet–Induced Hepatic Steatosis. The FASEB Journal, 40(6). https://doi.org/10.1096/fj.202503377r

Vancouver

Chen S, Fang F, Xu K, Zhang Z, Ji S, Huang Y, et al. Glucokinase Inactivation Reduces Lysophosphatidylcholine Accumulation to Alleviate High‐Fat Diet–Induced Hepatic Steatosis. The FASEB Journal. 2026;40(6). doi:10.1096/fj.202503377r

BibTeX
@article{Chen2026,
  author = {Chen, Shanshan and Fang, Fang and Xu, Ke and Zhang, Ziyue and Ji, Shuhui and Huang, Yadi and Li, Na and Qiao, Jingting and Wang, Junhe and Yu, Anting and Liu, Ming and Fan, Yuxin and Fan, Yu},
  title = {Glucokinase Inactivation Reduces Lysophosphatidylcholine Accumulation to Alleviate High‐Fat Diet–Induced Hepatic Steatosis},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1096/fj.202503377r}
}
Kostenlos starten →